These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38355887)

  • 1. Anti-obesity pharmacological agents for polycystic ovary syndrome: A systematic review and meta-analysis to inform the 2023 international evidence-based guideline.
    Goldberg A; Graca S; Liu J; Rao V; Witchel SF; Pena A; Li R; Mousa A; Tay CT; Pattuwage L; Teede H; Yildiz BO; Ee C
    Obes Rev; 2024 May; 25(5):e13704. PubMed ID: 38355887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the combined oral contraceptive pill and/or metformin in the management of polycystic ovary syndrome: A systematic review with meta-analyses.
    Teede H; Tassone EC; Piltonen T; Malhotra J; Mol BW; Peña A; Witchel SF; Joham A; McAllister V; Romualdi D; Thondan M; Costello M; Misso ML
    Clin Endocrinol (Oxf); 2019 Oct; 91(4):479-489. PubMed ID: 31087796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin and Combined Oral Contraceptive Pills in the Management of Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis.
    Melin J; Forslund M; Alesi S; Piltonen T; Romualdi D; Spritzer PM; Tay CT; Pena A; Witchel SF; Mousa A; Teede H
    J Clin Endocrinol Metab; 2024 Jan; 109(2):e817-e836. PubMed ID: 37554096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.
    Naderpoor N; Shorakae S; de Courten B; Misso ML; Moran LJ; Teede HJ
    Hum Reprod Update; 2015; 21(5):560-74. PubMed ID: 26060208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials.
    Alesi S; Forslund M; Melin J; Romualdi D; Peña A; Tay CT; Witchel SF; Teede H; Mousa A
    EClinicalMedicine; 2023 Sep; 63():102162. PubMed ID: 37583655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of pharmacological interventions on anthropometric indices in women with polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials.
    Abdalla MA; Shah N; Deshmukh H; Sahebkar A; Östlundh L; Al-Rifai RH; Atkin SL; Sathyapalan T
    Clin Endocrinol (Oxf); 2022 Jun; 96(6):758-780. PubMed ID: 34918367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological and surgical treatment of nonreproductive outcomes in polycystic ovary syndrome: An overview of systematic reviews.
    Tay CT; Joham AE; Hiam DS; Gadalla MA; Pundir J; Thangaratinam S; Teede HJ; Moran LJ
    Clin Endocrinol (Oxf); 2018 Nov; 89(5):535-553. PubMed ID: 29846959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome.
    Costello M; Shrestha B; Eden J; Sjoblom P; Johnson N
    Cochrane Database Syst Rev; 2007 Jan; (1):CD005552. PubMed ID: 17253562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of orlistat or metformin in overweight and obese polycystic ovary syndrome patients with insulin resistance.
    Song J; Ruan X; Gu M; Wang L; Wang H; Mueck AO
    Gynecol Endocrinol; 2018 May; 34(5):413-417. PubMed ID: 29172796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of statins, metformin, spironolactone and combined oral contraceptives in reducing testosterone levels in women with polycystic ovary syndrome: a network meta-analysis of randomized clinical trials.
    Almalki HH; Alshibani TM; Alhifany AA; Almohammed OA
    BMC Womens Health; 2020 Apr; 20(1):68. PubMed ID: 32248801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of metformin with or without lifestyle modification versus placebo on polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Melin J; Forslund M; Alesi S; Piltonen T; Romualdi D; Spritzer PM; Tay CT; Pena A; Witchel SF; Mousa A; Teede H
    Eur J Endocrinol; 2023 Aug; 189(2):S37-S63. PubMed ID: 37536294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined oral contraceptive pill compared with no medical treatment in the management of polycystic ovary syndrome: A systematic review.
    Forslund M; Melin J; Alesi S; Piltonen T; Romualdi D; Tay CT; Witchel S; Pena A; Mousa A; Teede H
    Clin Endocrinol (Oxf); 2023 Jul; 99(1):79-91. PubMed ID: 36939017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of exenatide alone or combined with metformin versus metformin in the treatment of polycystic ovaries: a systematic review and meta-analysis.
    Hu Y; Song X; Hamiti S; Ma Y; Yusufu M; Wang X; Zhang K; Guo Y
    BMC Endocr Disord; 2023 Nov; 23(1):250. PubMed ID: 37974132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating zinc-α2-glycoprotein is reduced in women with polycystic ovary syndrome, but can be increased by exenatide or metformin treatment.
    Zheng S; Liu E; Zhang Y; Long T; Liu X; Gong Y; Mai T; Shen H; Chen H; Lin R; Zheng Y; Xie Y; Wang F
    Endocr J; 2019 Jun; 66(6):555-562. PubMed ID: 30918134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of orlistat vs. metformin on weight loss-related clinical variables in women with PCOS: systematic review and meta-analysis.
    Graff SK; Mario FM; Ziegelmann P; Spritzer PM
    Int J Clin Pract; 2016 Jun; 70(6):450-61. PubMed ID: 27228266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis.
    Zhao H; Xing C; Zhang J; He B
    Reprod Health; 2021 Aug; 18(1):171. PubMed ID: 34407851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Oral Antidiabetic Drugs on Improving the Endocrine and Metabolic States in Women with Polycystic Ovary Syndrome: A Systematic Review and Network Meta-analysis.
    Yang S; Zhao L; He W; Mi Y
    Drugs; 2022 Sep; 82(14):1469-1480. PubMed ID: 36129662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different kinds of oral contraceptive pills in polycystic ovary syndrome: a systematic review and meta-analysis.
    Forslund M; Melin J; Alesi S; Piltonen T; Romualdi D; Tay CT; Witchel S; Pena A; Mousa A; Teede H
    Eur J Endocrinol; 2023 Jul; 189(1):S1-S16. PubMed ID: 37440702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effectiveness of metformin, oral contraceptives, and lifestyle modification in improving the metabolism of overweight women with polycystic ovary syndrome: a network meta-analysis.
    Wang A; Mo T; Li Q; Shen C; Liu M
    Endocrine; 2019 May; 64(2):220-232. PubMed ID: 30911997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
    Morley LC; Tang T; Yasmin E; Norman RJ; Balen AH
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD003053. PubMed ID: 29183107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.